Transforming growth factor-β, epidermal growth factor, and fibroblast growth factor are factors that activate signaling pathways to upregulate CD44, promoting tumor cell survival, invasion, and resistance to chemotherapy [13,44,46]. The gene discussed is CD44; the disease is neoplasm.